NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

MASI

Masimo Corp

Jun 20 • 04:00PM ET

165.18

Dollar change +2.41
Percentage change 1.48	%

Healthcare • Medical Devices • USA • NASD

Peers: MDT ABT TMO BSX EW GEHC ZBH HOLX NVCR BIO

| Held by: VTI IJH VB VXF VBK MDY IJK IHI SPMD IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.21	Insider Own	7.87%	Shs Outstand	54.20M	Perf Week	-0.10%
Market Cap	8.96B	Forward P/E	30.53	EPS next Y	5.41	Insider Trans	-0.98%	Shs Float	49.95M	Perf Month	5.77%
Enterprise Value	9.50B	PEG	-	EPS next Q	1.22	Inst Own	100.86%	Short Float	6.26%	Perf Quarter	-2.55%
Income	-494.50M	P/S	4.54	EPS this Y	13.08%	Inst Trans	6.47%	Short Ratio	4.80	Perf Half Y	-6.81%
Sales	1.97B	P/B	9.46	EPS next Y	8.72%	ROA	-10.54%	Short Interest	3.13M	Perf YTD	-0.07%
Book/sh	17.46	P/C	67.09	EPS next 5Y	12.00%	ROE	-23.93%	52W Range	101.61 - 194.88	Perf Year	22.05%
Cash/sh	2.46	P/FCF	53.53	EPS past 3/5Y	- -	ROIC	-30.83%	52W High	-15.24%	Perf 3Y	34.23%
Dividend Est.	-	EV/EBITDA	55.32	Sales past 3/5Y	19.12% 17.43%	Gross Margin	50.50%	52W Low	62.56%	Perf 5Y	-26.32%
Dividend TTM	-	EV/Sales	4.82	EPS Y/Y TTM	-713.82%	Oper. Margin	4.28%	Volatility	1.82% 2.05%	Perf 10Y	325.28%
Dividend Ex-Date	Nov 23, 2012	Quick Ratio	1.62	Sales Y/Y TTM	-0.12%	Profit Margin	-25.06%	RSI (14)	54.23	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	2.17	EPS Q/Q	-1006.54%	SMA20	1.85%	Beta	1.19	Target Price	183.71
Payout	-	Debt/Eq	0.72	Sales Q/Q	-24.51%	SMA50	3.75%	Rel Volume	0.97	Prev Close	162.77
Employees	9200	LT Debt/Eq	0.69	Earnings	May 06 AMC	SMA200	3.92%	Avg Volume	651.45K	Price	165.18
IPO	Aug 08, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.49% 1.11%	Trades		Volume	630,756	Change	1.48%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-27-24	Reiterated	Raymond James	Outperform	$170 → $194
Nov-06-24	Upgrade	Raymond James	Mkt Perform → Outperform	$170
Jun-03-24	Upgrade	Piper Sandler	Neutral → Overweight	$126 → $160
Apr-15-24	Upgrade	Stifel	Hold → Buy	$148 → $170
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$117 → $160
Jan-30-24	Downgrade	Jefferies	Buy → Hold	$107 → $121
Jan-03-24	Downgrade	Needham	Buy → Hold
Nov-08-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-18-23	Downgrade	Stifel	Buy → Hold	$205 → $120
Jul-10-23	Initiated	Wells Fargo	Equal Weight	$173
Feb-22-23	Upgrade	Raymond James	Mkt Perform → Outperform	$187
Dec-15-22	Upgrade	BTIG Research	Neutral → Buy	$180
Dec-05-22	Reiterated	Needham	Buy	$149 → $173
Oct-12-22	Initiated	Jefferies	Buy	$180
Sep-15-22	Upgrade	Wolfe Research	Peer Perform → Outperform	$165
Sep-14-22	Initiated	Loop Capital	Buy	$206
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$160
Feb-18-22	Upgrade	Needham	Hold → Buy	$205
Feb-16-22	Downgrade	Piper Sandler	Overweight → Neutral	$330 → $200
Oct-12-21	Resumed	Raymond James	Mkt Perform

Show Previous Ratings

Jun-10-25 08:00AM	New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia (Business Wire)
Jun-09-25 12:02AM	3 Reasons MASI is Risky and 1 Stock to Buy Instead (StockStory)
Jun-02-25 11:31PM	Reflecting On Patient Monitoring Stocks' Q1 Earnings: Masimo (NASDAQ:MASI) (StockStory)
May-27-25 12:59PM	Masimo says cyberattack will not prevent it from fulfilling orders (Cybersecurity Dive)
09:00AM	Masimo to Present in the Jefferies Global Healthcare Conference (Business Wire)
10:05AM	Loading…
May-19-25 10:05AM	MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds (StockStory)
May-09-25 10:11AM	Do You Believe in the growth potential of Masimo Corporation (MASI)? (Insider Monkey)
May-08-25 12:45PM	Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
May-07-25 01:09PM	COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised (Zacks) -7.04%
12:27PM	MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand (Zacks)
11:07AM	Masimo finds buyer for consumer audio business (MedTech Dive)
09:20AM	Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up (Zacks)
09:00AM	Masimo to Present in the BofA Securities 2025 Health Care Conference (Business Wire)
07:30AM	Q1 2025 Masimo Corp Earnings Call (Thomson Reuters StreetEvents)
05:36AM	Masimo says cyberattack has impacted its ability to fulfill orders (Cybersecurity Dive)
05:22AM	Loading…
05:22AM	Masimo to divest consumer audio division to Samsungs Harman (Verdict)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
03:19AM	Masimo Corp (MASI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Tariff Challenges (GuruFocus.com)
May-06-25 06:05PM	Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates (Zacks)
05:06PM	Samsung Electronics says unit Harman acquires Masimo's audio business for $350 million (Reuters)
04:32PM	Masimo to Sell Audio Business to Harman in $350 Million Deal (The Wall Street Journal)
04:10PM	Masimo to Sell Consumer Audio Business to HARMAN International (Business Wire)
04:10PM	Masimo Reports First Quarter 2025 Results (Business Wire)
07:10AM	NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash (Zacks)
May-05-25 12:59PM	ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket (Zacks)
11:09AM	Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss? (Zacks)
07:24AM	Teleflex Q1 Earnings Beat, '25 EPS View Down, Stock Up (Zacks)
May-02-25 01:22PM	SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View (Zacks)
01:21PM	DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins (Zacks)
08:03AM	TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up (Zacks)
07:58AM	Loading…
07:58AM	BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket (Zacks)
May-01-25 11:46AM	BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
11:34AM	ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
11:32AM	GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline (Zacks)
10:40AM	CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains (Zacks)
09:49AM	IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market (Zacks)
09:13AM	CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook (Zacks)
08:23AM	ALGN Q1 Earnings and Revenues Top Estimates, Stock Up in After-market (Zacks)
Apr-30-25 11:25AM	GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises (Zacks)
07:51AM	TECH Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
Apr-29-25 01:10PM	ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates (Zacks)
11:45AM	Baron Health Care Fund Q1 2025 Top Net Purchases And Sales (Seeking Alpha)
09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Apr-28-25 01:26PM	EMEA Growth & Product Launches to Support Boston Scientific Stock (Zacks)
01:18PM	RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up (Zacks)
11:24AM	Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y (Zacks)
09:19AM	HSIC Gears Up for Q1 Earnings: Here's What You Need to Know (Zacks)
Apr-27-25 02:22PM	Baron Health Care Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-25-25 12:50PM	Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now (Zacks)
12:48PM	Integer Holdings Q1 Earnings & Revenues Beat Estimates, Margins Expand (Zacks)
10:18AM	CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
10:02AM	Masimo: Priced Dearly Given Uncertainty (Seeking Alpha)
Apr-24-25 01:02PM	Here's Why You Should Add Veeva Stock to Your Portfolio Now (Zacks)
11:39AM	EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes (Zacks)
11:36AM	WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit (Zacks)
10:42AM	Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand (Zacks)
09:00AM	Masimo to Report First Quarter 2025 Financial Results after Market Close on Tuesday, May 6 (Business Wire)
07:25AM	AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise (Zacks)
07:24AM	ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market (Zacks)
06:43AM	EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised (Zacks)
Apr-23-25 12:53PM	Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up (Zacks)
12:39PM	ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts (Zacks)
09:47AM	BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised (Zacks)
Apr-22-25 11:34AM	Concentra Stock Slips Despite Deal to Acquire Pivot Onsite Innovations (Zacks)
10:34AM	Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up (Zacks)
08:13AM	Zimmer Biomet to Report Q1 Earnings: Here's What to Expect (Zacks)
07:29AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Apr-21-25 11:08AM	ECL Stock Gains Following 5% Trade Surcharge in the United States (Zacks)
08:34AM	IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? (Zacks)
Apr-18-25 12:10PM	Why Masimo (MASI) Could Beat Earnings Estimates Again (Zacks)
Apr-17-25 10:27AM	Why You Shouldn't Bet Against Masimo (MASI) Stock (Zacks)
09:12AM	Should You Continue to Hold Veracyte Stock in Your Portfolio? (Zacks)
09:00AM	Reasons to Hold TNDM Stock in Your Portfolio for Now (Zacks)
08:53AM	ALGN Gears Up for Q1 Earnings: What Lies Ahead for the Stock? (Zacks)
08:31AM	Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings (Zacks)
Apr-16-25 01:15PM	Will a Strong MA Business Aid Elevance Health's Q1 Earnings? (Zacks)
01:07PM	Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market (Zacks)
10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
10:21AM	Is it the Right Time to Hold STERIS Stock in Your Portfolio? (Zacks)
10:17AM	Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth (Zacks)
09:21AM	Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now (Zacks)
09:01AM	3 Healthcare Stocks Facing Headwinds (StockStory)
07:32AM	Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings (Zacks)
07:13AM	LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 (Zacks)
07:10AM	Here's Why You Should Retain Inogen Stock in Your Portfolio Now (Zacks)
Apr-15-25 11:20AM	HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold? (Zacks)
11:04AM	Merit Medical Stock Slips Despite the Launch of New Ventrax System (Zacks)
09:28AM	Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings (Zacks)
Apr-14-25 09:39AM	Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler (Zacks)
Apr-11-25 01:01PM	DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance (Zacks)
12:15PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
06:45AM	DGX Stock Gains Following the Launch of New AD-Detect Blood Test (Zacks)
12:30AM	Harbor Health Care ETF Q4 2024 Commentary (Seeking Alpha)
Apr-10-25 08:52AM	Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus (Zacks) -7.95%
07:29AM	Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract (Zacks)
07:25AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
07:16AM	Should You Continue to Hold NVST Stock in Your Portfolio? (Zacks)
Apr-09-25 01:35PM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks) +13.45%
01:30PM	Telix Shares May Gain on the Distribution Deal With Cardinal Health (Zacks)
09:52AM	Is it the Right Time to Retain Labcorp Stock in Your Portfolio? (Zacks)

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Muhsin Bilal	Chief Operating Officer	May 12 '25	Option Exercise	34.51	10,000	345,100	34,172	May 14 05:32 PM
Muhsin Bilal	Chief Operating Officer	May 12 '25	Sale	163.28	10,000	1,632,781	24,172	May 14 05:32 PM
REYNOLDS CRAIG B	Former Director	May 13 '25	Proposed Sale	164.00	16,443	2,696,652		May 13 04:44 PM
Muhsin Bilal	Officer	May 12 '25	Proposed Sale	163.24	10,000	1,632,386		May 12 04:39 PM
Chapek Robert A	Former Affiliate	May 12 '25	Proposed Sale	163.42	3,455	564,616		May 12 04:38 PM
Solomon Darlene J. S.	Director	Apr 29 '25	Option Exercise	0.00	1,790	0	1,790	May 02 08:55 AM
Scannell Timothy J	Director	Apr 29 '25	Option Exercise	0.00	1,383	0	1,383	May 02 08:54 AM
LANE WENDY E	Director	Apr 29 '25	Option Exercise	0.00	1,383	0	1,383	May 02 08:52 AM
Brennan Michelle	Chairman of the Board	Apr 29 '25	Option Exercise	0.00	1,790	0	7,118	May 01 09:58 PM
REYNOLDS CRAIG B	Director	Apr 29 '25	Option Exercise	0.00	1,790	0	18,371	May 01 09:53 PM
Chapek Robert A	Director	Apr 29 '25	Option Exercise	0.00	1,790	0	3,455	May 01 09:52 PM
Politan Capital Management LP	Director by deputization	Apr 29 '25	Option Exercise	0.00	1,790	0	4,716,536	May 01 08:33 PM
McClenahan Thomas Samuel	Former Officer	Apr 24 '25	Proposed Sale	162.95	26,300	4,285,475		Apr 24 04:20 PM
REYNOLDS CRAIG B	Director	Mar 14 '25	Sale	166.13	2,053	341,068	16,581	Mar 14 05:24 PM
REYNOLDS CRAIG B	Director	Mar 14 '25	Proposed Sale	166.13	2,053	341,068		Mar 14 04:10 PM
Muhsin Bilal	Chief Operating Officer	Mar 10 '25	Option Exercise	37.84	30,000	1,135,200	54,172	Mar 12 08:05 PM
Muhsin Bilal	Chief Operating Officer	Mar 10 '25	Sale	167.49	30,000	5,024,585	24,172	Mar 12 08:05 PM
Muhsin Bilal	Officer	Mar 10 '25	Proposed Sale	167.48	30,000	5,024,549		Mar 10 05:12 PM
Tripodi Blair	COO, Consumer Division	Mar 01 '25	Option Exercise	0.00	15,000	0	15,000	Mar 04 04:52 PM
Muhsin Bilal	Chief Operating Officer	Mar 01 '25	Option Exercise	0.00	15,000	0	32,270	Mar 04 04:48 PM
Young Micah W	EVP & Chief Financial Officer	Mar 01 '25	Option Exercise	0.00	15,000	0	25,536	Mar 04 04:44 PM
McClenahan Thomas Samuel	Officer	Mar 03 '25	Proposed Sale	191.13	49,000	9,365,578		Mar 03 04:44 PM
Levy Tao	Former Affiliate	Feb 28 '25	Proposed Sale	187.67	36,537	6,856,889		Mar 03 01:26 PM
KIANI JOE E	Former Affiliate	Jan 07 '25	Proposed Sale	165.65	302,165	50,052,375		Jan 07 05:36 PM
Levy Tao	Former Affiliate	Dec 16 '24	Proposed Sale	176.73	15,072	2,663,664		Dec 16 04:09 PM
Levy Tao	EVP, Bus Dev	Nov 13 '24	Option Exercise	0.00	30,000	0	41,208	Nov 15 06:05 PM
Politan Capital Management LP	Director by deputization	Jun 26 '24	Option Exercise	0.00	1,228	0	4,714,746	Sep 23 06:31 PM
Brennan Michelle	Director	Jun 26 '24	Option Exercise	0.00	1,228	0	1,228	Sep 23 06:22 PM
KIANI JOE E	CEO and Chairman of the Board	Aug 08 '24	Option Exercise	37.84	231,748	8,769,344	603,924	Aug 12 09:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MASI

Masimo Corp

Upgrade your FINVIZ experience